DE60008540D1 - Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen - Google Patents

Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen

Info

Publication number
DE60008540D1
DE60008540D1 DE60008540T DE60008540T DE60008540D1 DE 60008540 D1 DE60008540 D1 DE 60008540D1 DE 60008540 T DE60008540 T DE 60008540T DE 60008540 T DE60008540 T DE 60008540T DE 60008540 D1 DE60008540 D1 DE 60008540D1
Authority
DE
Germany
Prior art keywords
treating cancer
camptothecines
cancer diseases
aromatic esters
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60008540T
Other languages
English (en)
Other versions
DE60008540T2 (de
Inventor
Zhisong Cao
C Giovanella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stehlin Foundation for Cancer Research
Original Assignee
Stehlin Foundation for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stehlin Foundation for Cancer Research filed Critical Stehlin Foundation for Cancer Research
Application granted granted Critical
Publication of DE60008540D1 publication Critical patent/DE60008540D1/de
Publication of DE60008540T2 publication Critical patent/DE60008540T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60008540T 1999-08-03 2000-07-25 Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen Expired - Lifetime DE60008540T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US365633 1989-06-13
US09/365,633 US6228855B1 (en) 1999-08-03 1999-08-03 Aromatic esters of camptothecins and methods to treat cancers
PCT/US2000/020133 WO2001009139A1 (en) 1999-08-03 2000-07-25 Aromatic esters of camptothecins and methods to treat cancers

Publications (2)

Publication Number Publication Date
DE60008540D1 true DE60008540D1 (de) 2004-04-01
DE60008540T2 DE60008540T2 (de) 2004-07-29

Family

ID=23439682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008540T Expired - Lifetime DE60008540T2 (de) 1999-08-03 2000-07-25 Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen

Country Status (9)

Country Link
US (2) US6228855B1 (de)
EP (1) EP1200443B1 (de)
JP (1) JP5301066B2 (de)
AT (1) ATE260282T1 (de)
AU (1) AU6369900A (de)
CA (1) CA2380022C (de)
DE (1) DE60008540T2 (de)
ES (1) ES2213593T3 (de)
WO (1) WO2001009139A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999030727A1 (en) 1997-12-17 1999-06-24 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US6509027B2 (en) 2001-02-12 2003-01-21 Supergen, Inc. Injectable pharmaceutical composition comprising coated particles of camptothecin
US6534080B2 (en) 2001-02-12 2003-03-18 Super Gen, Inc. Method for administering camptothecins via injection of pharmaceutical composition comprising coated particles of a camptothecin
US6497896B2 (en) 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
US20020150615A1 (en) * 2001-02-12 2002-10-17 Howard Sands Injectable pharmaceutical composition comprising microdroplets of a camptothecin
US6699875B2 (en) * 2002-05-06 2004-03-02 The Stehlin Foundation For Cancer Research Cascade esters of camptothecins and methods of treating cancer using these compounds
US6703399B2 (en) * 2002-05-06 2004-03-09 The Stehlin Foundation For Cancer Research Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
ITRM20020306A1 (it) 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
CN100443486C (zh) * 2002-09-11 2008-12-17 中国医学科学院药物研究所 7-酯化和7,20-双酯化的喜树碱衍生物及其制法和其药物组合物与用途
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
WO2005062991A2 (en) * 2003-12-23 2005-07-14 American Bioscience, Inc. Ten and 20-di-esterification derivatives of camptothecins and methods to treat cancers
WO2005062985A2 (en) * 2003-12-23 2005-07-14 American Bioscience, Inc. Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
WO2005070936A1 (fr) * 2004-01-09 2005-08-04 Institute Of Mataria Medica, Chinese Academy Of Medical Sciences Derives de camptothecine 20-esterifies, preparation, compositions pharmaceutiques et utilisation
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
RU2441008C2 (ru) * 2006-08-11 2012-01-27 Дзе Кристус Стелин Фаундейшн Фор Кэнсер Рисерч Способы получения сложных эфиров камптотецинов
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
US20130121921A1 (en) 2011-11-11 2013-05-16 The Christus Stehlin Foundation For Cancer Research Rodent Therapeutic Model And Methods
CN115073483B (zh) * 2022-07-27 2022-10-25 泽升科技(广州)有限公司 一种伊立替康的对映体的制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894029A (en) 1971-08-26 1975-07-08 Basf Ag Production of camptothecin and camptothecin-like compounds
US4399282A (en) 1979-07-10 1983-08-16 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives
JPS56108787A (en) 1980-01-31 1981-08-28 Sato Yakugaku Kenkyusho:Kk Camptothecin coline salt and its preparation
US4473692A (en) * 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US5053512A (en) 1987-04-14 1991-10-01 Research Triangle Institute Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US4894456A (en) 1987-03-31 1990-01-16 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5227380A (en) * 1987-03-31 1993-07-13 Research Triangle Institute Pharmaceutical compositions and methods employing camptothecins
US5106742A (en) 1987-03-31 1992-04-21 Wall Monroe E Camptothecin analogs as potent inhibitors of topoisomerase I
US5180722A (en) 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS6461482A (en) 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5225404A (en) 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
SK283693B6 (sk) 1990-09-28 2003-12-02 Smithkline Beecham Corporation Spôsob prípravy kamptotecínu alebo jeho farmaceuticky prijateľnej soli
US5126351A (en) 1991-01-24 1992-06-30 Glaxo Inc. Antitumor compounds
WO1992014471A1 (en) 1991-02-21 1992-09-03 Smithkline Beecham Corporation Treatment of non-small cell lung carcinoma
US5391745A (en) 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
EP0664128A4 (de) 1992-10-07 1997-12-17 Sumitomo Pharma Pharmazeutisches mittel zur hemmung der tumornekrosefaktorproduktion.
US5552156A (en) 1992-10-23 1996-09-03 Ohio State University Liposomal and micellular stabilization of camptothecin drugs
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
EP0602361B1 (de) 1992-11-17 1997-01-22 C. Rob. Hammerstein GmbH Rückenlehnengelenk für einen Fahrzeugsitz
US5527913A (en) 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
US5352789A (en) 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
US5880131A (en) 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5840900A (en) 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
GB9402934D0 (en) 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
GB9410388D0 (en) 1994-05-24 1994-07-13 Erba Carlo Spa Method for the preparation of 9-amino camptothecin
US5786344A (en) 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5736156A (en) 1995-03-22 1998-04-07 The Ohio State University Liposomal anf micellular stabilization of camptothecin drugs
US5834012A (en) 1995-05-03 1998-11-10 Roman Perez-Soler Lipid complexed topoisomerase I inhibitors
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
SG50747A1 (en) 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
CA2192725C (en) 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
US5731316A (en) 1996-01-30 1998-03-24 The Stehlin Foundation For Cancer Research Derivatives of camptothecin and methods of treating cancer using these derivatives
WO1998007727A1 (en) 1996-08-19 1998-02-26 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
US5827533A (en) 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6111107A (en) 1997-11-20 2000-08-29 Enzon, Inc. High yield method for stereoselective acylation of tertiary alcohols

Also Published As

Publication number Publication date
ATE260282T1 (de) 2004-03-15
US20020049324A1 (en) 2002-04-25
US6407239B1 (en) 2002-06-18
DE60008540T2 (de) 2004-07-29
US6228855B1 (en) 2001-05-08
EP1200443A1 (de) 2002-05-02
ES2213593T3 (es) 2004-09-01
AU6369900A (en) 2001-02-19
EP1200443B1 (de) 2004-02-25
JP2003506378A (ja) 2003-02-18
WO2001009139A1 (en) 2001-02-08
CA2380022A1 (en) 2001-02-08
CA2380022C (en) 2010-10-19
JP5301066B2 (ja) 2013-09-25

Similar Documents

Publication Publication Date Title
DE60008540D1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
ATE334985T1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
EA200400944A1 (ru) Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
DE69611251T2 (de) Hydroperoxeicosatetraensäure derivate enthaltende zusammensetzungen und verfahren zur verwendung zur behandlung des trockenen auges
MX9803851A (es) Compuestos macrociclicos novedosos como inhibidores de metaloproteasas.
DE60225666D1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen enthaltend epothilon-analoga zur krebsbehandlung
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
EP1163208A4 (de) Caspase inhibitoren und deren verwendung
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE485818T1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
ATE251911T1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE60023555D1 (de) Verfahren zur behandlung von gewebe
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
ATE315387T1 (de) Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
DE60041266D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHRISTUS STEHLIN FOUNDATION FOR CANCER RESEARC, US